Related Experiment Videos
Short-term subcutaneous insulin infusion in diabetic children. Comparison with three daily insulin injections
Insights
Continuous subcutaneous insulin infusion (CSII) offers better overnight blood glucose control for children with insulin-dependent diabetes compared to intensified insulin treatment (3II), with fewer instances of hypoglycemia.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Diabetes Management
Background:
- Insulin-dependent diabetes in children requires effective management strategies.
- Intensified insulin treatment (3II) and continuous subcutaneous insulin infusion (CSII) are common therapeutic approaches.
Purpose of the Study:
- To compare the efficacy of 3II versus CSII in pediatric patients with insulin-dependent diabetes.
- To evaluate glycemic control and hypoglycemia incidence between the two treatment modalities.
Main Methods:
- A study involving sixteen pediatric patients with insulin-dependent diabetes.
- Comparison of glycemic control metrics (mean blood glucose, M-value, 24-h glycosuria) under 3II and CSII.
- Monitoring of symptomatic hypoglycemia events.
Main Results:
- Mean blood glucose, M-value, and 24-h glycosuria showed no significant difference between 3II and CSII.
- Symptomatic hypoglycemia was more frequent in patients receiving 3II.
- CSII demonstrated improved overnight blood glucose control, indicated by reduced early morning glucose peaks.
Conclusions:
- CSII provides superior overnight glycemic control in pediatric patients with insulin-dependent diabetes.
- CSII may reduce the risk of symptomatic hypoglycemia compared to 3II.
- Both treatment methods achieve similar overall glycemic control and glycosuria levels.
Abstract:
Sixteen insulin-dependent diabetic children and adolescents were studied on intensified insulin treatment (3II) and during continuous subcutaneous insulin infusion (CSII). Mean blood glucose, M-value and 24-h glycosuria were similar in both types of treatment. Symptomatic hypoglycemia occurred more often in patients on 3II than CSII. With 3II we observed blood glucose peaks early in the morning confirming that better overnight control can be achieved by CSII.